Edition:
United States

Insider Trading: Eli Lilly and Co (LLY.N)

LLY.N on New York Stock Exchange

83.89USD
23 Jun 2017
Change (% chg)

$-0.42 (-0.50%)
Prev Close
$84.31
Open
$84.12
Day's High
$84.34
Day's Low
$83.73
Volume
1,989,355
Avg. Vol
1,067,590
52-wk High
$86.71
52-wk Low
$64.25

LILLY ENDOWMENT INC
Trading Date Type Shares Traded Price Shares Held
19 Jun 2017 Sell 215,000 $83.05 124,475,804
29 Mar 2017 Sell 210,000 $84.67 124,690,804
26 Feb 2017 Sell 225,000 $83.06 124,900,804
16 Feb 2017 Sell 230,000 $80.27 125,125,804
31 Jan 2017 Sell 3,243 $78.04 125,355,804
31 Jan 2017 Sell 216,757 $77.34 125,355,804
15 Dec 2016 Sell 126,396 $72.32 125,575,804
15 Dec 2016 Sell 73,604 $73.07 125,575,804
28 Jul 2016 Sell 205,000 $82.94 125,775,804
27 Jul 2016 Sell 39,766 $83.13 125,980,804
27 Jul 2016 Sell 200,234 $82.82 125,980,804
11 Jul 2016 Sell 210,000 $79.54 126,220,804
6 Jul 2016 Sell 213,295 $79.11 126,430,804
6 Jul 2016 Sell 11,705 $79.71 126,430,804
29 Jun 2016 Sell 152,900 $78.60 126,655,804
29 Jun 2016 Sell 62,100 $78.14 126,655,804
28 Jun 2016 Sell 92,981 $78.09 126,870,804
28 Jun 2016 Sell 127,019 $77.70 126,870,804
30 May 2016 Sell 200,000 $75.12 127,090,804
11 May 2016 Sell 5,106 $76.60 127,290,804
11 May 2016 Sell 184,894 $75.84 127,290,804
28 Apr 2016 Sell 201 $76.10 127,480,804
28 Apr 2016 Sell 179,799 $75.44 127,480,804
7 Apr 2016 Sell 200,000 $74.29 127,660,804
20 Dec 2015 Sell 205,000 $86.00 127,860,804

Institutional Holders

% Shares Owned: 77.54%
# of Holders: 1,633
Total Shares Held: 855,534,062
3 Mo. Net Change: 9,102,736
# New Positions: 112
# Closed Positions: 67
# Increased Positions: 602
# Reduced Positions: 671
# Net Buyers: -69

Officers & Directors

Name Age Since Current Position

David Ricks

49 2017 Chairman of the Board, President, Chief Executive Officer

Derica Rice

52 2013 Chief Financial Officer, Executive Vice President - Global Services

Jan Lundberg

63 2010 Executive Vice President - Science and Technology, President - Lilly Research Laboratories

Melissa Barnes

48 2013 Senior Vice President - Enterprise Risk Management and Chief Ethics and Compliance Officer

Michael Harrington

54 2013 Senior Vice President, General Counsel

Stephen Fry

51 2011 Senior Vice President - Human Resources and Diversity

Enrique Conterno

50 2017 Senior Vice President and President - Lilly Diabetes and President - Lilly USA

Susan Mahony

52 2011 Senior Vice President and President - Lilly Oncology

Barton Peterson

58 2009 Senior Vice President - Corporate Affairs and Communications

Leigh Pusey

2017 Senior Vice President - Corporate Affairs and Communications

Jeffrey Simmons

49 2008 Senior Vice President and President - Elanco Animal Health

Fionnuala Walsh

57 2007 Senior Vice President - Global Quality

Alfonso Zulueta

54 2014 Senior Vice President and President - Emerging Markets

Ellen Marram

70 2013 Lead Independent Director

Raul Alvarez

61 2009 Independent Director

Katherine Baicker

45 2011 Independent Director

Carolyn Bertozzi

50 2017 Independent Director

Michael Eskew

67 2008 Independent Director

J. Erik Fyrwald

57 2005 Independent Director

R. David Hoover

71 2009 Independent Director

Jamere Jackson

47 2016 Independent Director

William Kaelin

59 2012 Independent Director

Juan Luciano

55 2016 Independent Director

Marschall Runge

62 2013 Independent Director

Kathi Seifert

67 1995 Independent Director

Jackson Tai

66 2013 Independent Director